HCWB HCW BIOLOGICS INC Capital Structure Changes 8-K Filing 2025 - Stock Split Approval On March 31, 2025, HCW Biologics Inc. stockholders approved a reverse stock split at a ratio of one-for-forty, effective April 11, 2025, to maintain its Nasdaq listing. Additionally, stockholders approved an equity line of credit and the conversion of $6.9 million in senior secured notes into shares.Get access to all SEC 8-K filings of the HCW BIOLOGICS INC